Floatz logo

Campath-1H

Hemophagocytic Lymphohistiocytosis (HLH)

Baylor College of Medicinemonoclonal_antibodyPhase 2Dormant
CCC
49/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
34/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Hemophagocytic Lymphohistiocytosis (HLH) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Beijing Tongren Hospital
Phase 4BBB
PEGASPARGASE
Beijing Tongren Hospital
Phase 4BB
Inno-206
The First Affiliated Hospital of Soochow University
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
Zhengzhou University
Phase 4BB
Zanubrutinib
The First Affiliated Hospital of Soochow University
Phase 4BB

View all 33 →

Same molecule, other indications

Campath-1H is also rated in:

MyelodysplasiaDormant
CCC
Indicative ·
55 / 100
View asset →
MyelomaDormant
CCC
Indicative ·
52 / 100
View asset →
myelodysplastic syndromeDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →